Cervical Cancer: NERLYNX® Added to NCCN Guidelines for HER2-Mutation

Cervical Cancer : NERLYNX® Added to NCCN Guidelines for HER2-Mutation Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company focused on advancing cancer treatments, has announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Cervical Cancer have been…

Read MoreCervical Cancer: NERLYNX® Added to NCCN Guidelines for HER2-Mutation

Hospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor

Hospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor Encompass Health Corp. (NYSE: EHC) has unveiled plans to construct a new 50-bed, freestanding inpatient rehabilitation hospital in Bangor, Maine, aimed at providing specialized care for patients recovering…

Read MoreHospital Unveils Promising Plans for a State-of-the-Art 50-Bed Rehabilitation Facility in Bangor
Announces

Exicure Announces Approval of $8.7 Million Equity Financing and Executive/Board Changes

Exicure, Inc. (Nasdaq: XCUR, “Exicure” or the “Company”), today announced that its stockholders approved a second investment of $8.7 million from HiTron Systems Inc. (“HiTron”), a publicly listed company on the KOSPI exchange in South Korea. This approval was in…

Read MoreExicure Announces Approval of $8.7 Million Equity Financing and Executive/Board Changes